男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / 2023CIIE

Expo to help accelerate MSD's Writing Our Future strategy

By YUAN SHENGGAO | China Daily | Updated: 2023-11-06 13:27
Share
Share - WeChat
Anna Van Acker, president of MSD in China and senior vice-president of MSD, gives a speech. CHINA DAILY

In pursuing a corporate strategy of "Writing Our Future", the top China executive of MSD said the global pharmaceutical company will continue to be a trusted leading partner in China's healthcare ecosystem for decades to come.

Anna Van Acker, president of MSD in China and senior vice-president of MSD, said the company's cutting-edge portfolio, innovative products and urgent sense of duty support the strategy, which was launched in 2021. She made the remarks ahead of the ongoing sixth China International Import Expo in Shanghai.

Other pillars for the company, which has a complete portfolio covering prevention to treatment and will preside over the CIIE Pharma Committee this year, include improving accessibility and affordability for patients and consumers, sustaining long-term partnerships with customers and strengthening capabilities in data analysis, digitalization, and lifecycle management of products at different stages so they have greater value for patients, Van Acker said.

"China has tremendous unmet medical needs that will only be exacerbated in the future as the country is home to a fast aging population. That's why we must dream of a world where cancer isn't just treated, but potentially cured," added Van Acker. "At MSD, we have a sense of urgency and are moving at full speed ahead to save more lives from cancer with a vast development program."

By conducting more than 80 clinical trials covering 20 types of tumors, MSD expects to bring new treatment options to more Chinese physicians and patients in the coming years. The company's therapies have long been used for public health causes in China, including treating more than 10 million patients in 2022 alone.

Van Acker said that in order to continue riding the wave of China's medical care development, MSD will make further moves to improve accessibility and affordability by pursuing innovative access solutions and pan-industry partnerships along the patient journey of prevention, diagnosis and treatment, and keep long-term partnerships with customers to improve the quality of academic engagement and create solutions with stakeholders.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 临安市| 基隆市| 凤阳县| 曲水县| 台东市| 荔波县| 普洱| 西乡县| 大宁县| 红河县| 于都县| 新宾| 临沭县| 凤城市| 隆子县| 青州市| 岚皋县| 巴林左旗| 于都县| 乌审旗| 东安县| 黔东| 青铜峡市| 松阳县| 宜黄县| 颍上县| 乳源| 临夏市| 平塘县| 大安市| 洪洞县| 吴川市| 汝阳县| 东乌珠穆沁旗| 鹿泉市| 威宁| 兰考县| 哈尔滨市| 天津市| 沾益县| 天门市|